Ondine Becquart

Montpellier, 34295, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma.

Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma.

Journal: Cancers

Published: May 18, 2021

Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases.

Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases.

Journal: Melanoma research

Published: August 14, 2020

Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.

Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.

Journal: Cancers

Published: March 04, 2020

Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Journal: PloS one

Published: November 06, 2019

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors.

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: June 28, 2019

Hydrochlorothiazide use and risk of skin cancers: A systematic review

Hydrochlorothiazide use and risk of skin cancers: A systematic review

Journal: La Revue de medecine interne

Published: December 20, 2018

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.

Journal: Cell reports

Published: October 18, 2018

Angiosarcoma of the head and neck treated with bevacizumab and paclitaxel

Angiosarcoma of the head and neck treated with bevacizumab and paclitaxel

Journal: Annales de dermatologie et de venereologie

Published: August 07, 2017

PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.

PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.

Journal: Oncoimmunology

Published: February 24, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026